Oriola Oyj Stock Fundamentals

O5O Stock  EUR 0.90  0.04  4.65%   
Oriola Oyj fundamentals help investors to digest information that contributes to Oriola Oyj's financial success or failures. It also enables traders to predict the movement of Oriola Stock. The fundamental analysis module provides a way to measure Oriola Oyj's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Oriola Oyj stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Oriola Oyj Company Return On Equity Analysis

Oriola Oyj's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current Oriola Oyj Return On Equity

    
  0.0217  
Most of Oriola Oyj's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Oriola Oyj is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, Oriola Oyj has a Return On Equity of 0.0217. This is 100.09% lower than that of the Healthcare sector and significantly higher than that of the Pharmaceutical Retailers industry. The return on equity for all Germany stocks is 107.0% lower than that of the firm.

Oriola Oyj Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oriola Oyj's current stock value. Our valuation model uses many indicators to compare Oriola Oyj value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oriola Oyj competition to find correlations between indicators driving Oriola Oyj's intrinsic value. More Info.
Oriola Oyj is regarded third in return on equity category among its peers. It also is regarded third in return on asset category among its peers reporting about  0.55  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Oriola Oyj is roughly  1.82 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oriola Oyj's earnings, one of the primary drivers of an investment's value.

Oriola Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Oriola Oyj's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Oriola Oyj could also be used in its relative valuation, which is a method of valuing Oriola Oyj by comparing valuation metrics of similar companies.
Oriola Oyj is regarded second in return on equity category among its peers.

Oriola Fundamentals

About Oriola Oyj Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Oriola Oyj's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oriola Oyj using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oriola Oyj based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally.The company offers various range of OTC and traded good, vitamins, dietary supplements, pharmaceutical cosmetics, skincare products, tests, sports drinks, and wound care products. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. ORIOLA OYJ operates under Pharmaceutical Retailers classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2768 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Oriola Stock

Oriola Oyj financial ratios help investors to determine whether Oriola Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oriola with respect to the benefits of owning Oriola Oyj security.